No Data
Express News | Xiangyu Medical: Planning to repurchase shares of 50 million yuan to -0.1 billion yuan.
Shanghai SHY(688626): Performance continues to be under pressure, waiting quietly for the medical industry to recover.
Investment highlights: The company is a leading research and development enterprise in the domestic rehabilitation medical instruments industry. It mainly focuses on rehabilitation assessment (including evaluating muscle strength, neurological disorders, degree of functional loss, etc.), rehabilitation training (including rehabilitation training equipment for exercise, active and passive training, etc.).
Express News | The Development and Reform Commission of Henan Province held a symposium for private enterprises.
Xiangyu Medical Report for the Third Quarter of 2024
Xiayu Medical (688626.SH): The net income for the first three quarters was 73.4139 million yuan, a year-on-year decrease of 59.02%.
Gelonghui October 29th | Xiangyu Medical (688626.SH) announced that in the first three quarters of 2024, revenue was 0.507 billion yuan, a decrease of 6.50% year-on-year; net income attributable to shareholders of the listed company was 73.4139 million yuan, a decrease of 59.02% year-on-year; basic earnings per share was 0.47 yuan.
Express News | The Medical medical 'spray gun for a low-temperature cryotherapy device' has been granted a patent.
No Data
No Data